Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

Choose more journals

Article type Check one or more article types to show results from those article types only.
Subject Check one or more subjects to show results from those subjects only.
Date Choose a date option to show results from those dates only.

Custom date range

Clear all filters
Sort by:
Showing 1–3 of 3 results
Advanced filters: Author: Behzad Hajarizadeh Clear advanced filters

  • Globally, 130–170 million people have HCV infection; however, distribution patterns are highly variable. This Review outlines the latest information on the epidemiology and natural history of HCV infection. The disease burden and mortality of HCV-related diseases, and the potential effect of HCV treatment on disease burden, are also outlined.

    • Behzad Hajarizadeh
    • Jason Grebely
    • Gregory J. Dore
    Reviews
    Nature Reviews Gastroenterology & Hepatology
    Volume: 10, P: 553-562

  • Direct-acting antiviral agents (DAAs) are highly effective treatments for HCV, but are not always accessible to people who inject drugs (PWID). Here, Grebely and colleagues outline the epidemiology of HCV in PWID, discuss current data on DAA outcomes in this population and highlight steps required to broaden access to HCV therapy with the eventual goal of HCV elimination.

    • Jason Grebely
    • Behzad Hajarizadeh
    • Gregory J. Dore
    Reviews
    Nature Reviews Gastroenterology & Hepatology
    Volume: 14, P: 641-651

  • Direct-acting antiviral agents (DAAs) have revolutionized the management of chronic hepatitis C, but their use in acute infection is unclear. This Review outlines the epidemiology, diagnosis and management of acute HCV infection, providing insights into the use of DAAs in at-risk populations (such as people who inject drugs).

    • Marianne Martinello
    • Behzad Hajarizadeh
    • Gail V. Matthews
    Reviews
    Nature Reviews Gastroenterology & Hepatology
    Volume: 15, P: 412-424